432 filings
Page 12 of 22
424B5
wljq3v4j989f1ux iqr1
11 Dec 17
Prospectus supplement for primary offering
12:00am
8-K
0p5g4fyoc7ms8u
8 Dec 17
Cancer Genetics Prices $7.0 Million Registered Direct Offering
12:00am
8-K
rtljxgh
27 Nov 17
Cancer Genetics Appoints Renowned Biotech Entrepreneur Dr. Thomas F. Widmann to its Board of Directors
12:00am
8-K
s3g5e8p jmx7
9 Nov 17
Cancer Genetics Reports Record Third Quarter 2017 Revenue and 134% Increase in Contracted Bookings from Major Biotech and Pharmaceutical Companies
12:00am
8-K/A
p0nl lxrlni1
27 Oct 17
Completion of Acquisition or Disposition of Assets
12:00am
8-K
v7lu6d5b 8pwz578
16 Aug 17
Entry into a Material Definitive Agreement
12:00am
424B5
xr0htbu cxud82rh3g
16 Aug 17
Prospectus supplement for primary offering
12:00am
8-K
86agn4u 45tz4b93q
14 Aug 17
Cancer Genetics, Inc. Announces Second Quarter 2017 Financial Results, Accretive Acquisition and Capital Raise
12:00am
8-K
ghqd3k95l3foojq4oa
7 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
EFFECT
t03s7g
5 Jun 17
Notice of effectiveness
12:00am
CORRESP
ucyn8j40s6wn
1 Jun 17
Correspondence with SEC
12:00am
UPLOAD
ksuhv1xjb7hd882d2dxy
31 May 17
Letter from SEC
12:00am
8-K
343jkp4
12 May 17
Results of Operations and Financial Condition
12:00am
DEFA14A
vak2lg3bn1n0gdyu
21 Apr 17
Additional proxy soliciting materials
12:00am
D
ycp384y
27 Mar 17
$6M in debt / options, sold $6M, 3 investors
12:00am